Upgrade for detailed insurance, legislation, and other documents analytics for individual cases; real-time analysis of the datasets from your EHR, CRM, ERP, or other software; and more Enterprise Features.
Invasive female breast cancer, predominantly adenocarcinoma, Stage IIIA-IIIB (not T3, N1, M0), ER/PR positive, no progression/recurrence/metastasis, not ductal carcinoma in situ.
2025 HCPCS code G9054
Supervising, coordinating, or managing care of a patient with terminal cancer or for whom other medical illness prevents further cancer treatment.
2025 HCPCS code G9107
Oncology - other
2025 HCPCS code G9068
Oncology disease status limited to small cell and combined small cell/non-small cell; extent of disease initially established as limited with no evidence of disease progression, recurrence, or metastases (for use in a Medicare-approved demonstration project).
2025 HCPCS code G9113
Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage IA-B (grade 1) without recurrence or progression.
2025 HCPCS code G9109
头颈部癌的疾病状态，仅限于以鳞状细胞为主要细胞类型的口腔癌、咽癌和喉癌，未显示疾病进展。
2025 HCPCS code G9107
肿瘤学-其他
2025 HCPCS code G9080
Oncología - Otros
2025 HCPCS code G9137
Oncology; disease status; Non-Hodgkin’s lymphoma, any cellular classification; relapsed/refractory (for use in a Medicare-approved demonstration project).
2025 HCPCS code G9135
Oncology; Disease status; Non-Hodgkin’s lymphoma, any cellular classification; Stage III, IV, not relapsed, not refractory.
2025 HCPCS code G9098
Cancer of the esophagus, adenocarcinoma or squamous cell carcinoma, metastatic, recurrent, or progressive disease status.
2025 HCPCS code G9134
Non-Hodgkin’s lymphoma, stage I/II, any cell type, not relapsed/recurrent, nonrefractory.
2025 HCPCS code G9128
Multiple Myeloma, Stage IA
2025 HCPCS code G9080
Oncology - Other
2025 HCPCS code G9132
Oncology - Other
2025 HCPCS code G9104
Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed.
2025 HCPCS code G9136
Disease status of non-Hodgkin’s lymphoma with transformation of cell type from one classification to another (Used in a Medicare demonstration project in 2006).
2025 HCPCS code G9102
Oncology; disease status; gastric cancer, limited to adenocarcinoma, clinical or pathologic M0, unresectable with no evidence of disease progression (for use in a Medicare-approved demonstration project).
2025 HCPCS code G9126
Chronic Myelogenous Leukemia, positive for Philadelphia chromosome or BCR/ABL gene, in remission.
2025 HCPCS code G9061
Available practice guidelines do not address the patient's specific cancer condition.
2025 HCPCS code G9109
Disease status of head and neck cancer, limited to cancers of the oral cavity, pharynx, and larynx with squamous cell as the predominant cell type, showing no disease progression.
2025 HCPCS code G9069
Oncology - disease status; small cell lung cancer (limited to small cell and combined small cell/non-small cell); extensive stage at diagnosis, metastatic, locally recurrent, or progressive. For use in a Medicare-approved demonstration project.
2025 HCPCS code G9094
Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a Medicare-approved demonstration project).
2025 HCPCS code G9014
ESRD demo expanded bundle including venous access and related services.
2025 HCPCS code G9060
Oncology - Management Differs From Practice Guidelines.
2025 HCPCS code G9016
Smoking cessation counseling, individual, per session (6-10 minutes), used in Medicare demonstration projects.
2025 HCPCS code G9071
Oncology - Current Disease Status, Invasive Female Breast Cancer, Adenocarcinoma as Predominant or Main Cell Type, Stage I or IIA to IIB, or T3, N1, M0 Category, ER and/or PR Positive Type, Not Ductal Carcinoma, No Evidence of Disease Progression, Recurrence, or Metastasis
2025 HCPCS code G9095
Oncology – other. This code reports a patient's disease status for a Medicare demonstration project when the patient has rectal cancer that is predominantly adenocarcinoma, and the extent is unknown, staging is in progress, or the extent is not listed.
2025 HCPCS code G9131
Oncology - Other
2025 HCPCS code G9130
Oncology - Other
2025 HCPCS code G9129
Oncology - Other (Medicare demonstration project, 2006)
2025 HCPCS code G9074
Oncology - other. This code is used for reporting the disease status of invasive female breast cancer within a Medicare-approved demonstration project, specifically for cases where the cancer is predominantly adenocarcinoma, Stage IIIA to IIIB, not T3, N1, or M0, and is estrogen and progesterone receptor-negative (ER/PR-), excluding ductal carcinoma.
2025 HCPCS code G9089
Oncology - disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or extent not listed in patient record.
2025 HCPCS code G9103
Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic M1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a Medicare-approved demonstration project).
2025 HCPCS code G9059
Indicates that a cancer patient's management differs from practice guidelines due to their choice of alternative treatment or no treatment after guideline-consistent treatment was offered.
2025 HCPCS code G9135
Oncología; estado de la enfermedad; linfoma no hodgkiniano, cualquier clasificación celular; estadio <a href="../medical-coding/reference/III" target="_blank" title="Medical Code III 2025">III</a>, <a href="../medical-coding/reference/IV" target="_blank" title="Medical Code IV 2025">IV</a>, no recidivante ni resistente al tratamiento.
2025 HCPCS code G9136
Estado patológico del linfoma no hodgkiniano con transformación del tipo de célula de una clasificación a otra (utilizado en un proyecto de demostración de Medicare en 2006).
2025 HCPCS code G9137
Onkolohiya; katayuan ng sakit; Non-Hodgkin's lymphoma, anumang selular na pag-uuri; muling bumabag/refractory (para magamit sa isang proyekto ng demonstrasyon na naaprubahan ng Medicare).
2025 HCPCS code G9137
Oncología; estado de la enfermedad; linfoma no hodgkiniano, cualquier clasificación celular; recidivante o resistente al tratamiento (para su uso en un proyecto de demostración aprobado por Medicare).
2025 HCPCS code G9137
Ung thư; tình trạng bệnh; U lympho không Hodgkin, bất kỳ phân loại tế bào nào; tái pháp/chịu lửa (để sử dụng trong một dự án trình diễn được Medicare phê duyệt).
2025 HCPCS code G9137
Oncologie ; état de la maladie ; lymphome non hodgkinien, quelle que soit sa classification cellulaire ; récidivant/réfractaire (à utiliser dans le cadre d'un projet de démonstration approuvé par Medicare).
2025 HCPCS code G9137
Onkologie; Krankheitsstatus; Non-Hodgkin-Lymphom, beliebige Zellklassifikation, rezidiviert/therapieresistent (zur Verwendung in einem von Medicare zugelassenen Demonstrationsprojekt).
2025 HCPCS code G9126
Leucemia mielógena crónica, positiva para el cromosoma Filadelfia o el gen <a href="../medical-coding/reference/BCR" target="_blank" title="Medical Code BCR 2025">BCR/</a> <a href="../medical-coding/reference/ABL" target="_blank" title="Medical Code ABL 2025">ABL</a>, en remisión.
2025 HCPCS code G9136
Tình trạng bệnh ung thư hạch không Hodgkin với sự chuyển đổi loại tế bào từ phân loại này sang phân loại khác (Được sử dụng trong một dự án trình diễn Medicare vào năm 2006).
2025 HCPCS code G9136
세포 유형이 한 분류에서 다른 분류로 변형된 비호지킨 림프종의 질병 상태 (2006년 메디케어 시범 프로젝트에 사용).
2025 HCPCS code G9136
État de la maladie du lymphome non hodgkinien avec transformation du type cellulaire d'une classification à une autre (utilisé dans le cadre d'un projet de démonstration Medicare en 2006).
2025 HCPCS code G9136
Krankheitsstatus des Non-Hodgkin-Lymphoms mit Transformation des Zelltyps von einer Klassifikation zur anderen (2006 in einem Medicare-Demonstrationsprojekt verwendet).
2025 HCPCS code G9135
<a href="../medical-coding/reference/IV" target="_blank" title="Medical Code IV 2025">종양학, 질병 상태, 비호지킨 림프종, 모든 세포 분류, 단계 <a href="../medical-coding/reference/III" target="_blank" title="Medical Code III 2025">III</a>, IV, 재발하지 않았음, 불응성 없음</a>
2025 HCPCS code G9135
肿瘤学；疾病状况；非霍奇金淋巴瘤，任何细胞分类；III 期、<a href="../medical-coding/reference/III" target="_blank" title="Medical Code III 2025">I <a href="../medical-coding/reference/IV" target="_blank" title="Medical Code IV 2025">V</a> 期，未复发</a>，非难治性。
2025 HCPCS code G9135
Onkolohiya; Katayuan ng sakit; Non-Hodgkin's lymphoma, anumang selular na pag-uuri; Stage <a href="../medical-coding/reference/III" target="_blank" title="Medical Code III 2025">III</a>, <a href="../medical-coding/reference/IV" target="_blank" title="Medical Code IV 2025">IV, hindi bumalik</a>, hindi refraktory.
Continue with Personal Account
Thank you for exploring iFrame ♥ Please subscribe for unlimited access to our top-tier AI model, which directly supports our dedicated knowledge creators maintaining an ad-free internet experience.